Table 3.
CMR characteristics of patients without fibrosis at baseline
| |
Baseline |
Sixmonths |
P |
|---|---|---|---|
| N= 17 | N= 17 | ||
| LVEF (%) |
63.9±14.6 |
67.6±76.5 |
0.15 |
| LVEDV (ml) |
152.7±57.5 |
154.7±44.2 |
0.82 |
| LVEDVi (ml/m2) |
87.1±35 |
87.0±25.2 |
0.99 |
| LVESV (ml) |
60±48.8 |
51.1±22.7 |
0.27 |
| LVESVi (ml/m2) |
34.5±29 |
28.9±13.4 |
0.25 |
| LVM (g) |
148.0±50.4 |
124.7±41.8 |
0.000 |
| LVMi (g/m2) |
83.9±28.9 |
69.5±22.3 |
0.000 |
| Stroke volume (ml) |
90.9±20 |
98.5±28 |
0.57 |
| CardiacOutput (L/min) | 5.9±1.3 | 6.2±1.3 | 0.98 |
CMR cardiovascular magnetic resonance; LVEDVi indexed left ventricular end diastolic volume; LVESVi indexed left ventricular end systolic volume; LVMi indexed left ventricular mass; LVEDV left ventricular end diastolic volume; LVEF left ventricular ejection fraction; LVM left ventricular mass; LVESV left ventricular end systolic volume.